Dr. Sharmila Dorbala, MBBS, MPH

Claim this profile

Brigham and Women's Hospital

Studies Amyloidosis
Studies Amyloid Polyneuropathy
4 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.

Brigham And Women's Hospital

Clinical Trials Sharmila Dorbala, MBBS, MPH is currently running

Image of trial facility.

Ultrasound Therapy

for Cardiac Amyloidosis

This is a prospective pilot clinical study of subjects with cardiac amyloidosis and control subjects without amyloidosis where we plan to evaluate changes in myocardial blood flow, systolic and diastolic function before and after sonotherapy.

Recruiting

3 awards

Phase 4

5 criteria

Image of trial facility.

[68Ga]CBP8 PET/MRI Imaging

for Cardiac Amyloidosis

The primary aim of our pilot study is to determine whether fibrosis in the heart can be measured with \[68Ga\]CBP8, a positron emission tomography (PET) probe, using PET/magnetic resonance imaging (MRI) imaging, in 30 individuals with documented cardiac amyloidosis. The investigators will also enroll 15 individuals with recent myocardial infarction and 15 individuals with hypertrophic cardiomyopathy as positive controls for fibrosis, and the investigators will enroll 5 individuals without cardiovascular disease to undergo \[68Ga\]CBP8 PET/MRI imaging as a healthy control group. The primary hypothesis of this study is that \[68Ga\]CBP8 will bind to interstitial collagen and quantify myocardial fibrosis in patients with cardiac amyloidosis. The investigators hypothesize that \[68Ga\]CBP8 uptake will be greater in patients with cardiac amyloidosis, myocardial fibrosis, and hypertrophic cardiomyopathy than in healthy controls. Secondly, the investigators also hypothesize that \[68Ga\]CBP8 activity more strongly correlates with standard MRI measures in patients with recent myocardial infarction and hypertrophic cardiomyopathy (where extracellular expansion is caused by myocardial fibrosis/collagen deposition) than in patients with cardiac amyloidosis (where myocardial fibrosis is combined with infiltration).

Recruiting

1 award

Phase 3

5 criteria

More about Sharmila Dorbala, MBBS, MPH

Clinical Trial Related

2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Sharmila Dorbala, MBBS, MPH has experience with

  • F-18 Florbetapir/C-11 Acetate PET
  • MRI
  • N-13 Ammonia PET
  • [68Ga]CBP8 PET/MRI
  • Sonotherapy
  • F-18 Florbetapir PET

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Sharmila Dorbala, MBBS, MPH specialize in?

Is Sharmila Dorbala, MBBS, MPH currently recruiting for clinical trials?

Are there any treatments that Sharmila Dorbala, MBBS, MPH has studied deeply?

What is the best way to schedule an appointment with Sharmila Dorbala, MBBS, MPH?

What is the office address of Sharmila Dorbala, MBBS, MPH?

Is there any support for travel costs?